Paloma Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-5,163
| Closed | -$287K | – | 1920 |
|
|
2019
Q2 | $287K | Sell |
5,163
-2,507
| -33% | -$139K | ﹤0.01% | 1088 |
|
|
2019
Q1 | $387K | Buy |
+7,670
| New | +$387K | 0.01% | 891 |
|
|
2018
Q1 | – | Sell |
-6,082
| Closed | -$325K | – | 1645 |
|
|
2017
Q4 | $325K | Sell |
6,082
-2,588
| -30% | -$138K | ﹤0.01% | 929 |
|
|
2017
Q3 | $517K | Buy |
8,670
+4,803
| +124% | +$286K | 0.01% | 967 |
|
|
2017
Q2 | $305K | Buy |
+3,867
| New | +$305K | ﹤0.01% | 1289 |
|
|
2014
Q3 | – | Sell |
-14,363
| Closed | -$206K | – | 1246 |
|
|
2014
Q2 | $206K | Buy |
+14,363
| New | +$206K | 0.01% | 873 |
|